Navigation Links
Analyzing The Side Effects Of Sirolimus Stents

Based on findings of a recent study researchers from Sweden say they have found that implantation //of a sirolimus-eluting stent is associated with coronary vasoconstriction in areas adjacent to the treated vessel that is not seen with bare metal stents.

Sirolimus-eluting stents are widely used for percutaneous coronary interventions because of their excellent long-term clinical and angiographic outcome, however, recent concerns have been raised that the stents could lead to increased rates of stent thrombosis due to delayed or absent endothelialization.

Researchers compared endothelial function and coronary vasomotor response to exercise in 14 patients fitted with sirolimus-eluting stents and 11 control patients receiving bare metal stents. It was observed that after 6 months, the reference vessel showed an increase in exercise-induced vasodilation in both groups, with a mean increase in diameter of 13%, and no vasomotion in the stented vessel segments. In adjacent segments that were proximal and distal to the bare metal stent there were also increases in exercise-induced vasodilation of 15% and 17%, respectively. In contrast, exercise-induced vasoconstriction - indicating endothelial dysfunction - occurred with the sirolimus-eluting stent at these locations, with decreases in vessel diameter of 12% and 15%, respectively (p<0.001 vs controls). Vasodilatory capacity was preserved, with sublingual nitroglycerin associated with maximal vasodilation of these vessel segments in both groups.

Researchers are of the opinion that Paradoxic vasoconstriction in a vessel segment not subjected to percutaneous transluminal coronary angioplasty barotrauma may be due to diffusion of the antiproliferative drug from the stent to the peri-stent region, inducing endothelial dysfunction. However some are of the opinion that inadequate endothelial coverage could lead to insufficient nitric oxide to promote normal vasodilation with exercise. In concl usion researchers say that they will not be able to come to any positive finding, until further studies are done in this field.

For more information read:
http://www.medindia.net/
interactives/angioplasty.asp

'"/>




Related medicine news :

1. Analyzing The Side Effects Of Some Common Medications
2. Analyzing The Risk Factors For Diabetic Neuropathy
3. Analyzing Client-Centered Therapy.
4. Acupuncture May Help Chemotherapy Side Effects
5. Chemotherapy Pill Has Fewer Side Effects Than IV
6. Therapy Boosts Chemotherapy Effects
7. Smoking and its Effects
8. Reducing The After Effects of Tonsillectomy
9. The Side Effects Of Estrogen Therapy
10. The Harmful Effects Of Cigarette Smoke
11. Lung Therapy Found To Have Long-Term Side Effects
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/24/2017)... ... ... Millions of families and businesses worldwide depend on high quality water from ... water. However, well water can also become contaminated with bacteria and odors from flood ... The EPA does not regulate private drinking water wells. Many states and towns do ...
(Date:9/24/2017)... ... ... boy was walking home and feeling down about himself. He didn’t think he was good ... he can do whatever he wants to do if he puts his mind to it. ... God created him with special talents and gifts. We see his internal dialogue change. He ...
(Date:9/24/2017)... ... ... The Other Sheep”: the ceremonial laws of Moses and the Holy Law of God reexamined. ... author, Maurice Caines. Maurice Caines resides in the sunny isle of Florida, but he ... Adventist Church for many years. He was previously a member of the Anglican Church ...
(Date:9/23/2017)... San Francisco, CA (PRWEB) , ... September 23, 2017 , ... ... Bay Area, is proud to announce a new blog post focused on the ARTAS® ... loss, they understandably hope to turn to the latest, most technologically sophisticated methods of ...
(Date:9/22/2017)... Albert Lea, MN (PRWEB) , ... September 22, 2017 , ... ... and video) at its rally to interview citizens on why they are rallying against ... stories and commitment to this effort against Dr. Noseworthy’s (CEO) decision to close the ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
(Date:9/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... will be participating in the Morgan Stanley 15 th ... hotel in New York.  Zimmer Biomet will present on ... A live webcast of the presentation can ... http://investor.zimmerbiomet.com .   ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
Breaking Medicine Technology: